Rebecka Ahl1,2, Peter Matthiessen2,3, Yang Cao4, Gabriel Sjolin2,5, Olle Ljungqvist6,7, Shahin Mohseni8,9. 1. Department of Surgery, Karolinska University Hospital, Stockholm, Sweden. 2. School of Medical Sciences, Örebro University, Örebro, Sweden. 3. Division of Colorectal Surgery, Department of Surgery, Örebro University Hospital, Örebro, Sweden. 4. Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden. 5. Department of Surgery, Örebro University Hospital, Örebro, Sweden. 6. Department of Surgery, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. 7. Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden. 8. School of Medical Sciences, Örebro University, Örebro, Sweden. shahin.mohseni@regionorebrolan.se. 9. Division of Trauma and Emergency Surgery, Department of Surgery, Örebro University Hospital, Örebro, Sweden. shahin.mohseni@regionorebrolan.se.
Abstract
BACKGROUND: Emergency surgery for colon cancer carries significant morbidity, and studies show more than doubled mortality when comparing elective to emergency surgery. The relationship between postoperative complications and survival has been outlined. Beta-blocker therapy has been linked to improved postoperative outcomes. This study aims to assess the impact of postoperative complications on long-term survival following emergency surgery for colon cancer and to determine whether beta-blockade can reduce complications. STUDY DESIGN: This cohort study utilized the prospective Swedish Colorectal Cancer Registry to identify adults undergoing emergency colon cancer surgery between 2011 and 2016. Prescription data for preoperative beta-blocker therapy were collected from the national drug registry. Cox regression was used to evaluate the effect of beta-blocker exposure and complications on 1-year mortality, and Poisson regression was used to evaluate beta-blocker exposure in patients with major complications. RESULTS: A total of 3139 patients were included with a mean age of 73.1 [12.4] of which 671 (21.4%) were prescribed beta-blockers prior to surgery. Major complications occurred in 375 (11.9%) patients. Those suffering major complications showed a threefold increase in 1-year mortality (adjusted HR = 3.29; 95% CI 2.75-3.94; p < 0.001). Beta-blocker use was linked to a 60% risk reduction in 1-year mortality (adjusted HR = 0.40; 95% CI 0.26-0.62; p < 0.001) but did not show a statistically significant association with reductions in major complications (adjusted IRR = 0.77; 95% CI 0.59-1.00; p = 0.055). CONCLUSION: The development of major complications after emergency colon cancer surgery is associated with increased mortality during one year after surgery. Beta-blocker therapy may protect against postoperative complications.
BACKGROUND: Emergency surgery for colon cancer carries significant morbidity, and studies show more than doubled mortality when comparing elective to emergency surgery. The relationship between postoperative complications and survival has been outlined. Beta-blocker therapy has been linked to improved postoperative outcomes. This study aims to assess the impact of postoperative complications on long-term survival following emergency surgery for colon cancer and to determine whether beta-blockade can reduce complications. STUDY DESIGN: This cohort study utilized the prospective Swedish Colorectal Cancer Registry to identify adults undergoing emergency colon cancer surgery between 2011 and 2016. Prescription data for preoperative beta-blocker therapy were collected from the national drug registry. Cox regression was used to evaluate the effect of beta-blocker exposure and complications on 1-year mortality, and Poisson regression was used to evaluate beta-blocker exposure in patients with major complications. RESULTS: A total of 3139 patients were included with a mean age of 73.1 [12.4] of which 671 (21.4%) were prescribed beta-blockers prior to surgery. Major complications occurred in 375 (11.9%) patients. Those suffering major complications showed a threefold increase in 1-year mortality (adjusted HR = 3.29; 95% CI 2.75-3.94; p < 0.001). Beta-blocker use was linked to a 60% risk reduction in 1-year mortality (adjusted HR = 0.40; 95% CI 0.26-0.62; p < 0.001) but did not show a statistically significant association with reductions in major complications (adjusted IRR = 0.77; 95% CI 0.59-1.00; p = 0.055). CONCLUSION: The development of major complications after emergency colon cancer surgery is associated with increased mortality during one year after surgery. Beta-blocker therapy may protect against postoperative complications.
Authors: Shahin Mohseni; Peep Talving; Eric P Thelin; Göran Wallin; Olle Ljungqvist; Louis Riddez Journal: World J Surg Date: 2015-08 Impact factor: 3.352
Authors: Eric J Ley; Jeff Scehnet; Ryan Park; Stu Schroff; Grant Dagliyan; Peter S Conti; Daniel R Margulies; Ali Salim Journal: J Trauma Date: 2009-01
Authors: C Fuchs; S Wauschkuhn; C Scheer; M Vollmer; K Meissner; S-O Kuhn; K Hahnenkamp; A Morelli; M Gründling; S Rehberg Journal: Br J Anaesth Date: 2017-10-01 Impact factor: 9.166
Authors: Yin Zhang; Mingyang Song; Andrew T Chan; Jeffrey A Meyerhardt; Walter C Willett; Edward L Giovannucci Journal: Br J Cancer Date: 2022-09-22 Impact factor: 9.075
Authors: Ahmad Mohammad Ismail; Tomas Borg; Gabriel Sjolin; Arvid Pourlotfi; Sebastian Holm; Yang Cao; Per Wretenberg; Rebecka Ahl; Shahin Mohseni Journal: Trauma Surg Acute Care Open Date: 2020-07-29
Authors: Lovisa Ekestubbe; Gary Alan Bass; Maximilian Peter Forssten; Gabriel Sjölin; Yang Cao; Peter Matthiessen; Rebecka Ahl Hulme; Shahin Mohseni Journal: Sci Rep Date: 2022-03-28 Impact factor: 4.379
Authors: Ahmad Mohammad Ismail; Rebecka Ahl; Maximilian Peter Forssten; Yang Cao; Per Wretenberg; Tomas Borg; Shahin Mohseni Journal: J Trauma Acute Care Surg Date: 2022-01-01 Impact factor: 3.697